China Resources Pharmaceutical Group Limited Share Price
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
01:38:20 21/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 4.530 HKD | -2.69% |
|
-1.95% | +1.80% |
| 19/10 | China Resources Pharma Unit Raises 900 Billion Yuan Via Bonds Issue | MT |
| 01/10 | China Resources Pharmaceuticals Needs More Than Distribution Scale to Win |  |
| Market Cap | 2.92TCr 372.62Cr 331.67Cr 307.39Cr 278.55Cr 523.49Cr 35TCr 532.25Cr 3.69TCr 1.45TCr 18TCr 1.4TCr 1.37TCr 59TCr | P/E 2026 * |
5.97x | P/E 2027 * | 5.6x |
|---|---|---|---|---|---|
| Enterprise Value | 7.85TCr 999.94Cr 890.05Cr 824.89Cr 747.49Cr 1.4TCr 95TCr 1.43TCr 9.9TCr 3.89TCr 50TCr 3.75TCr 3.67TCr 1,58100Cr | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.21x |
| Free-Float |
29.17% | Yield 2026 * |
4.37% | Yield 2027 * | 4.73% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 3320 | Delayed | |
Tradegate
| 640 | Real-time | |
|
Deutsche Boerse AG
| 640 | Delayed | |
|
Börse Stuttgart
| 640 | Delayed | |
|
Boerse Muenchen
| 640 | Real-time |
| 1 day | -2.69% | ||
| 1 week | -1.95% | ||
| Current month | +1.80% | ||
| 1 month | +3.42% | ||
| 3 months | -5.03% | ||
| 6 months | -26.22% | ||
| Current year | +1.80% |
| 1 week | 4.5 |  | 4.76 |
| 1 month | 4.22 | | 4.76 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 20/06/2016 |
Xiao Song Bai
CHM | Chairman | 55 | 29/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/04/20 | Other | Chief Executive Officer | 2,00,000 | 0.0032% | ||
| 31/03/20 | Other | Chief Executive Officer | 1,00,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.69% | -1.95% | -5.43% | -4.23% | 372.62Cr | |
| +3.49% | +10.04% | +58.68% | +119.56% | 1,14400Cr | |
| +2.19% | +4.32% | +33.88% | +69.52% | 63TCr | |
| +2.26% | +5.37% | +24.57% | +97.69% | 51TCr | |
| +0.27% | +5.37% | +39.17% | +64.51% | 38TCr | |
| +3.25% | +4.45% | +71.80% | +44.44% | 37TCr | |
| +0.29% | +3.44% | +21.35% | +50.15% | 29TCr | |
| +0.14% | +2.75% | +1.31% | +25.13% | 26TCr | |
| +3.29% | +6.32% | +44.71% | +57.43% | 24TCr | |
| +2.25% | +5.81% | +27.13% | +101.17% | 19TCr | |
| Average | +0.56% | +6.02% | +31.72% | +62.54% | 40.12TCr | |
| Weighted average by Cap. | +0.50% | +6.91% | +40.97% | +81.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33TCr 4.18TCr 3.72TCr 3.45TCr 3.12TCr 5.87TCr 3,95700Cr 5.97TCr 41TCr 16TCr 2,07100Cr 16TCr 15TCr 6,60600Cr | 34TCr 4.34TCr 3.86TCr 3.58TCr 3.25TCr 6.1TCr 4,11300Cr 6.2TCr 43TCr 17TCr 2,15200Cr 16TCr 16TCr 6,86600Cr |
| Net income | 482.39Cr 61Cr 55Cr 51Cr 46Cr 86Cr 5.82TCr 88Cr 608.4Cr 239.01Cr 3.05TCr 230.55Cr 225.77Cr 9.72TCr | 517.8Cr 66Cr 59Cr 54Cr 49Cr 93Cr 6.25TCr 94Cr 653.06Cr 256.55Cr 3.27TCr 247.47Cr 242.34Cr 10TCr |
| Net Debt | 4.92TCr 627.32Cr 558.38Cr 517.5Cr 468.94Cr 881.31Cr 59TCr 896.06Cr 6.21TCr 2.44TCr 31TCr 2.35TCr 2.3TCr 99TCr | 4.25TCr 541.87Cr 482.32Cr 447.01Cr 405.06Cr 761.26Cr 51TCr 774.01Cr 5.36TCr 2.11TCr 27TCr 2.03TCr 1.99TCr 86TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | HK$4.530 | -2.69% | 87,19,000 |
| 20/26/20 | HK$4.655 | +1.09% | 98,80,500 |
| 16/26/16 | HK$4.605 | -2.23% | 75,32,028 |
| 15/26/15 | HK$4.710 | +1.95% | 1,61,09,099 |
| 14/26/14 | HK$4.620 | +2.67% | 1,33,92,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
